Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Carlo Incerti sold 16,500 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $28.73, for a total value of $474,045.00. The sale was disclosed in a document filed with the SEC, which is available […]

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) CTO Metin Kurtoglu sold 34,400 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $18.39, for a total value of $632,616.00. Following the completion of the sale, the chief technology officer now owns 51,033 shares […]